In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
A new Learning Center website will launch on Monday, March 30, 2020. While the link to the new Learn...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...